PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Hjalmarson, Åke
TI  - Rosuvastatin Offers No Significant Benefit for Older Patients with Heart Failure
DP  - 2007  01
TA  - MD Conference Express
PG  - 13--14
VI  - 7
IP  - 7
4099  - http://mdc.sagepub.com/content/7/7/13.short
4100  - http://mdc.sagepub.com/content/7/7/13.full
AB  - Rosuvastatin was found to have no significant benefit in the prevention of cardiovascular death, myocardial infarction, or stroke in symptomatic older patients with systolic heart failure of ischemic etiology in the Controlled Rosuvastatin Multinational [CORONA] trial. However, statin therapy was associated with significantly fewer hospitalizations and significantly decreased levels of low-density lipoprotein compared with placebo.